Tag: Drug Approvals
FDA Grants Fast-Track Approval to Ovarian Cancer Drug
Rubraca's use is specific to women with deleterious BRCA mutations
FDA OKs Autologous Cellularized Scaffold for Knee Cartilage Repair
For symptomatic, full-thickness cartilage defects of the knee in adult patients
FDA Approves Intrarosa for Postmenopausal Pain During Sex
Drug contained in a once-daily vaginal insert
FDA Approves Device to Prevent Recurrent Strokes in PFO Patients
For patients who had prior stroke related to patent foramen ovale
FDA Approves New Treatment for Advanced Soft Tissue Sarcoma
Sanctioned for use with doxorubicin in cases that cannot be treated with radiation or surgery
FDA Approves ‘Artificial Pancreas’ for Type 1 Diabetes
MiniMed 670G hybrid closed loop system automatically monitors glucose, delivers insulin
FDA Approves First Drug for Duchenne Muscular Dystrophy
Exondys 51 sanctioned for patients with mutation of the dystrophin gene amenable to exon 51 skipping
FDA Approves Balloon Device for Eustachian Tube Dysfunction
Designed to relieve pressure, pain, or clogged or muffled sensations occuring in the ear
FDA Approves Biosimilar Drug Erelzi for Rheumatoid Arthritis
Erelzi is a biosimilar for Enbrel; treats RA and other inflammatory diseases
FDA Approves First Generic Version of Tamiflu
Oseltamivir phosphate does not take the place of receiving a flu vaccination
